Page 35 - Biomedical Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Russia's Sputnik V Vaccine 91.6% Effective: Lancet Study By Kelly MACNAMARA 02/02/21 AT 9:41 AM Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to results published Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out. Sputnik V -- named after the Soviet-era satellite -- was approved in Russia months before results from its final-stage clinical trials were published, leading to scepticism from experts. But the new analysis of data from 20,000 Phase 3 trail participants, published ...

Peer-reviewed study finds Russia's COVID vaccine is 91.6% effective February 2, 2021 / 9:29 AM / AFP China, Russia using vaccines to expand reach Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic COVID-19 infection, according to results published in The Lancet on Tuesday that some independent experts say should allay transparency concerns over the jab, which Moscow is already rolling out. Sputnik V — named after the Soviet-era satellite — was approved in Russia months before results from its final-stage clinical trials were published, leading to skepticism f...

Russia's Sputnik V Vaccine 91.6% Effective In Late-Stage Trial: Lancet Russia's Sputnik V Vaccine 91.6% Effective In Late-Stage Trial: Lancet Sputnik V -- named after the Soviet-era satellite -- was approved in Russia months before results from its final-stage clinical trials were published, leading to scepticism from experts. Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, according to The Lancet Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to results published in The Lancet on Tuesday that independent experts said allaye...

Channels Television   Updated February 2, 2021 A health worker receives a dose of the Sputnik V vaccine against COVID-19, at the basketball court of Argentine club River Plate, bellow the grandstand of the Monumental stadium, in Buenos Aires on February 2, 2020. Juan MABROMATA / AFP   Russia’s Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to results published Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out. Sputnik V — named after the Soviet-era satellite — was approved in ...

The interim trial results of Sputnik V, the coronavirus vaccine developed by Russia, are in, and results are showing 91.6 percent effectiveness in preventing symptomatic cases, as reported by CNN. There were no severe adverse events that appeared to be associated with the vaccine and the only side effects reported being mild, consisting of flu-like symptoms, pain at the injection site and low energy. Following the phase three trial of the vaccine, interim data suggests that two doses of Sputnik V reach a comparable level of effectiveness to those developed by Pfizer and Moderna. It also appe...